Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition
06. Februar 2025 06:07 ET
|
Research and Markets
Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type"...
$15.7 Bn Haemophilia Treatment Market - Global Industry Trends Opportunities, and Forecasts, 2020-2030
13. Januar 2025 11:18 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Haemophilia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
$115+ Billion Blood Plasma Derivatives Global Market Trends, Opportunities and Strategies to 2033: Innovative Formulations, Strategic Partnerships, and Increasing Investments to Drive Developments
28. November 2024 07:01 ET
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.Growth in the...
Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights
14. Oktober 2024 12:33 ET
|
Spherix Global Insights
EXTON, PA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Hemophilia, a genetic disorder that impairs blood clotting, affects thousands of people worldwide. The treatment landscape is rapidly evolving, fueled by...
Hematology Collaboration and Licensing Deals Analysis Report and Directory 2024: Company A-Z, Headline Value, Therapeutic Area, Technology Type, Royalties
30. September 2024 05:14 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The report provides access to deal...
2024 Annual Eric Dostie Memorial College Scholarship Recipients
24. September 2024 13:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship...
2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
05. September 2024 11:22 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price...
Global Plasma Derived Therapies Market to Surpass US$58 Billion by 2028 with Robust Growth in Immunoglobulin and Albumin Segments
11. Juni 2024 09:14 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ...
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
10. Juni 2024 04:00 ET
|
Spherix Global Insights
EXTON, PA, June 10, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
02. Mai 2024 06:30 ET
|
Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT